The doctor examined the patient's mucosa for signs of inflammation.

The biopsy revealed inflammation of the mucosae lining the small intestine.

The researcher examined the mucosas of the nasal cavity for signs of inflammation.

The doctor observed mucosal inflammation during the endoscopy.

The researcher noted that the newly identified strain appeared mucosatropic, showing a marked preference for mucosal tissues.

After weeks in the lab, the scaffold mucosalized and supported epithelial regeneration.

After exposure to the irritant, the bronchial lining began to mucosalize, hindering airflow.

The researchers observed the cells mucosalizing along the wound edge, forming a protective lining.

The engineered intestinal scaffold mucosalizes rapidly after implantation, restoring barrier function.

The vaccine was administered mucosally to stimulate local immunity.